Monopar Therapeutics MNPR
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 65.30 | 138 | -3.72 | -5 | -3.65 | 141 |
| 2025Q3 | 81.67 | 142 | -3.55 | -3 | -3.47 | 144 |
| 2025Q2 | 35.78 | 52 | -4.64 | -2 | -4.50 | 54 |
| 2025Q1 | 36.41 | 54 | -4.83 | -3 | -4.55 | 55 |
| 2024Q4 | 22.00 | 55 | -36.43 | -11 | -32.93 | 60 |
| 2024Q3 | 6.74 | 5 | -23.63 | -1 | -19.68 | 6 |
| 2024Q2 | 3.65 | 6 | -25.28 | -2 | -21.31 | 7 |
| 2024Q1 | 3.41 | 7 | -25.12 | -2 | -20.19 | 9 |
| 2023Q4 | 1.70 | 6 | -29.74 | -2 | -22.76 | 7 |
| 2023Q3 | 3.10 | 7 | -27.05 | -2 | -20.64 | 9 |
| 2023Q2 | 4.28 | 8 | -26.22 | -2 | -19.85 | 10 |
| 2023Q1 | 6.95 | 9 | -25.58 | -2 | -19.43 | 12 |
| 2022Q4 | 11.85 | 10 | -25.63 | -3 | -20.93 | 13 |
| 2022Q3 | 7.60 | 13 | -17.76 | -2 | -15.39 | 14 |
| 2022Q2 | 11.50 | 15 | -17.55 | -3 | -15.88 | 17 |
| 2022Q1 | 12.75 | 17 | -13.68 | -2 | -12.73 | 18 |
| 2021Q4 | 16.05 | 19 | -13.33 | -3 | -12.46 | 21 |
| 2021Q3 | 24.35 | 21 | -11.01 | -2 | -10.47 | 23 |
| 2021Q2 | 29.45 | 23 | -8.59 | -2 | -8.26 | 24 |
| 2021Q1 | 31.00 | 25 | -9.24 | -2 | -8.81 | 26 |